Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antimicrobial Peptide LL-37 (Cathelicidin) Production in Active Tuberculosis Disease: Role of Vitamin D Supplementation

NCT00788320 is registered in ClinicalTrials.gov with Atlanta VA Medical Center as lead sponsor.

NCT NCT00788320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00788320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antimicrobial Peptide LL-37 (Cathelicidin) Production in Active Tuberculosis Disease: Role of Vitamin D Supplementation
Lead sponsor
Atlanta VA Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2008
Completion date
February 28, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis